Type 1 News
- 24 June 2018
- Diabetes News
Here is an interesting article, but not yet scientifically proven. It should be read with caution as it could turn out to be another false hope. The article is not indicative of the views of the Surrey Downs Group.
An experimental therapy for type 1 diabetes, widely derided by mainstream diabetes researchers, lowered blood sugar levels to near normal, a small, ongoing trial found. Patients in the trial, whose blood sugar levels have remained near normal for five to eight years, take about one-third less insulin than they did before, reducing their risk of hypoglycemia, in which insulin lowers blood sugar to dangerously low levels.
The experimental treatment, a decades-old generic vaccine for tuberculosis called bacillus Calmette-Guérin (BCG), seems to alter both cellular metabolism and the immune system, said Dr. Denise Faustman of Massachusetts General Hospital, senior author of the study published Thursday in npj Vaccines. “This cheap, old vaccine is lowering blood sugar to levels never achieved before,” she said.
We understand that the trial is at 2nd stage in a wider group of humans in the US.
Reducing the amount of insulin needed is great especially if it can be reduced to zero. If blood sugars are near normal at 5-8 years this would also reduce the microvascular complications of having abnormal levels of blood glucose (above 5-7).